Link to an article by Jonathan Latham:
“The Biotech Industry is Taking Over the Regulation of GMOs From the Inside”
The central dispute between industry and critics like Latham is over which of two approaches to adopt: (1) reasonably prove safety before commercial release, or (2) presume safety (and permit commercial release) until harm is proven. See also “Unsafe at any Dose? Diagnosing Chemical Safety Failures, from DDT to BPA”